Cita APA (7a ed.)

Fu, Q., Shen, Q., Tong, J., Huang, L., Cheng, Y., & Zhong, W. (2021). Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer. Frontiers Media S.A.

Cita Chicago Style (17a ed.)

Fu, Qiang, Qian Shen, Jin Tong, Liu Huang, Yi Cheng, y Wei Zhong. Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer. Frontiers Media S.A, 2021.

Cita MLA (8a ed.)

Fu, Qiang, et al. Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer. Frontiers Media S.A, 2021.